EMA Authorised: Mixtard (Insulin human) — Novo Nordisk A/S

View source ↗

Summary

Mixtard (insulin human) by Novo Nordisk A/S has been authorised for use in the EU for diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Mixtard (insulin isophane (NPH) and regular insulin)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Novo Nordisk A/S. Decision date: 24/01/2024